Analysis of Antibody A6 Binding to the Extracellular Interferon γ Receptor α-Chain by Alanine-Scanning Mutagenesis and Random Mutagenesis with Phage Display
- 1 December 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 39 (51) , 15674-15685
- https://doi.org/10.1021/bi000838z
Abstract
The monoclonal antibody A6 binds a conformational epitope comprising mainly the CC' surface loop on the N-terminal fibronectin type-III domain of the extracellular interferon gamma receptor (IFNgammaR). The crystal structure of an A6 Fab-IFNgammaR complex revealed an interface rich in the aromatic side chains of Trp, Tyr, and His residues. These aromatic side chains appear to interact with both polar and hydrophobic groups at the interface, a property which, in general, may be advantageous for ligand binding. To analyze these interactions in more detail, the affinities of 19 A6 alanine-scanning mutants for the IFNgammaR have been measured, using engineered A6 single chain variable region fragments, and a surface plasmon resonance biosensor. Energetically important side chains (DeltaG(mutant) - DeltaG(wt) > 2.4 kcal/mol), that form distinct hot spots in the binding interface, have been identified on both proteins. These include V(L)W92 in A6, whose benzenoid ring appears well situated for a pi-cation (or pi-amine) interaction with the side chain of receptor residue K47 and simultaneously for T-stacking onto the indole ring of W82 in the receptor. At another site, energetically important residues V(H)W52 and V(H)W53, as well as V(H)D54 and V(H)D56, surround the aliphatic side chain of the hot receptor residue K52. Taken together, the results show that side chains distributed across the interface, including many aromatic ones, make key energetic contributions to binding. In addition, the receptor CC' loop has been subjected to random mutagenesis, and receptor mutants with high affinity for A6 have been selected by phage display. Residues previously identified as important for receptor binding to A6 were conserved in the clones isolated. Some mutants, however, showed a much improved affinity for A6, due to changes at Glu55, a residue that appeared to be energetically unimportant for binding the antibody by alanine-scanning mutagenesis. An E55P receptor mutant bound A6 with a 600-fold increase in affinity (K(D) approximately 20 pM), which is one of the largest improvements in affinity from a single point mutation reported so far at any protein-protein interface.Keywords
This publication has 15 references indexed in Scilit:
- On the importance of being aromatic at an antibody-protein antigen interface: mutagenesis of the extracellular interferon γ receptor and recognition by the neutralizing antibody A6Journal of Molecular Biology, 1999
- Anatomy of hot spots in protein interfacesJournal of Molecular Biology, 1998
- Neutralizing epitopes on the extracellular interferon γ receptor (IFNγR) α-chain characterized by homolog scanning mutagenesis and X-ray crystal structure of the A6 Fab-IFNγR 1-108 complex 1 1Edited by R. HuberJournal of Molecular Biology, 1997
- USE OF SURFACE PLASMON RESONANCE TO PROBE THE EQUILIBRIUM AND DYNAMIC ASPECTS OF INTERACTIONS BETWEEN BIOLOGICAL MACROMOLECULESAnnual Review of Biophysics, 1997
- Role of Salt Bridge Formation in Antigen-Antibody InteractionJournal of Biological Chemistry, 1996
- Isolation of Picomolar Affinity Anti-c-erbB-2 Single-chain Fv by Molecular Evolution of the Complementarity Determining Regions in the Center of the Antibody Binding SiteJournal of Molecular Biology, 1996
- Role of Tyr Residues in the Contact Region of Anti-lysozyme Monoclonal Antibody HyHEL10 for Antigen BindingPublished by Elsevier ,1995
- Recombinant anti‐sialidase single‐chain variable fragment antibodyEuropean Journal of Biochemistry, 1994
- Crystallization of Single-Chain Fv ProteinsJournal of Molecular Biology, 1993
- Purification of human gamma interferon receptors by sequential affinity chromatography on immobilized monoclonal antireceptor antibodies and human gamma interferon.The Journal of Experimental Medicine, 1987